FierceBiotech 2025-12-02 Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss
FierceBiotech 2025-12-02 Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality
FierceBiotech 2025-12-02 Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
FierceBiotech 2025-12-02 FDA adopts agentic AI in latest push to infuse artificial intelligence into agency
FierceBiotech 2025-12-01 European Union teams up with Angelini to funnel €150M to European health startups
FierceBiotech 2025-12-01 Akebia to pay $12M to Q32 Bio for centerpiece of rare kidney disease pipeline
FierceBiotech 2025-12-01 Meeting patients where they are: tailored support to drive recruitment and retention
FierceBiotech 2025-11-26 Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles